| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -4.7e-05 | 1 |